PharmaNutra SpA (761) Stock Statistics & Valuation Metrics
Total Valuation
PharmaNutra SpA has a market cap or net worth of EUR 687.35M. The enterprise value is EUR 842.83M.
- Market Cap
- EUR 687.35M
- Enterprise Value
- EUR 842.83M
Share Statistics
PharmaNutra SpA has 9,680,977 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 9,680,977
- Owned by Insiders
- ―
- Owned by Institutions
- 1.78%
Financial Efficiency
PharmaNutra SpA’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 20.15%.
- Return on Equity (ROE)
- 0.28
- Return on Assets (ROA)
- 0.16
- Return on Invested Capital (ROIC)
- 20.15%
- Return on Capital Employed (ROCE)
- 0.32
- Revenue Per Employee
- 914.49K
- Profits Per Employee
- 138.90K
- Employee Count
- 144
- Asset Turnover
- 1.05
- Inventory Turnover
- 11.52
Valuation Ratios
The current PE Ratio of PharmaNutra SpA is 32.94. PharmaNutra SpA’s PEG ratio is 1.42.
- PE Ratio
- 32.94
- PS Ratio
- 4.81
- PB Ratio
- 9.87
- Price to FCF
- 45.76
- Price to Operating Cash Flow
- 36.04
- PEG Ratio
- 1.42
Income Statement
In the last 12 months, PharmaNutra SpA had revenue of 131.69M and earned 20.00M in profits. Earnings per share was 2.09.
- Revenue
- 131.69M
- Gross Profit
- 29.71M
- Operating Income
- 30.31M
- Pretax Income
- 30.19M
- Net Income
- 20.00M
- EBITDA
- 34.21M
- Earnings Per Share (EPS)
- 2.09
Cash Flow
In the last 12 months, operating cash flow was 19.08M and capital expenditures -4.05M, giving a free cash flow of 15.02M billion.
- Operating Cash Flow
- 19.08M
- Free Cash Flow
- 15.02M
- Free Cash Flow per Share
- 1.57
Dividends & Yields
PharmaNutra SpA pays an annual dividend of ―, resulting in a dividend yield of 1.64%
- Dividend Per Share
- ―
- Dividend Yield
- 1.64%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.19%
- Earnings Yield
- 3.02%
Stock Price Statistics
- Beta
- 0.37
- 52-Week Price Change
- 53.66%
- 50-Day Moving Average
- 74.33
- 200-Day Moving Average
- 77.03
- Relative Strength Index (RSI)
- 46.99
- Average Volume (3m)
- 23
Important Dates
PharmaNutra SpA upcoming earnings date is Nov 09, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 11, 2026
- Next Earnings Date
- Nov 09, 2026
- Ex-Dividend Date
- ―
Financial Position
PharmaNutra SpA as a current ratio of 2.35, with Debt / Equity ratio of 28.75%
- Current Ratio
- 2.35
- Quick Ratio
- 2.06
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.06
- Interest Coverage Ratio
- 27.86
Taxes
In the past 12 months, PharmaNutra SpA has paid 10.27M in taxes.
- Income Tax
- 10.27M
- Effective Tax Rate
- 0.34
Enterprise Valuation
PharmaNutra SpA EV to EBITDA ratio is -139.09, with an EV/FCF ratio of 46.50.
- EV to Sales
- 4.89
- EV to EBITDA
- -139.09
- EV to Free Cash Flow
- 46.50
- EV to Operating Cash Flow
- 36.62
Balance Sheet
PharmaNutra SpA has EUR 15.14M in cash and marketable securities with EUR 18.36M in debt, giving a net cash position of -EUR 3.22M billion.
- Cash & Marketable Securities
- EUR 15.14M
- Total Debt
- EUR 18.36M
- Net Cash
- -EUR 3.22M
- Net Cash Per Share
- -EUR 0.33
- Tangible Book Value Per Share
- EUR 4.67
Margins
Gross margin is 26.77%, with operating margin of -2.92%, and net profit margin of 14.52%.
- Gross Margin
- 26.77%
- Operating Margin
- -2.92%
- Pretax Margin
- 21.64%
- Net Profit Margin
- 14.52%
- EBITDA Margin
- -3.52%
- EBIT Margin
- -6.44%
Analyst Forecast
The average price target for PharmaNutra SpA is EUR 97.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 97.00
- Price Target Upside
- 36.04% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 2
- Revenue Growth Forecast
- 17.69%
- EPS Growth Forecast
- 23.06%
